Everything NICE has said on diagnosing and managing Parkinson's disease in adults in primary and secondary care in an interactive flowchart
Everything NICE has said on assessing and managing motor neurone disease in adults in an interactive flowchart
Evidence-based recommendations on the EXOGEN ultrasound bone healing system for long bone fractures with non-union or delayed healing
Everything NICE has said on musculoskeletal conditions in an interactive flowchart
NICE quality standards set out priority areas for quality improvement in health and social care.
We use 3 processes for assessing technologies: the single technology appraisal, the multiple technology appraisal and the fast track appraisal.
Everything NICE has said on familial hypercholesterolaemia in an interactive flowchart
Everything NICE has said on shared decision-making and processes to optimise medicines and support adherence in an interactive flowchart
This guideline covers identifying and managing familial hypercholesterolaemia (FH), a specific type of high cholesterol that runs in the family, in children, young people and adults. It aims to help identify people at increased risk of coronary heart disease as a result of having FH.
Draft guidance published today (3 October 2019) by NICE does not recommend atezolizumab (also called Tecentriq and made by Roche) for treating people with a type of breast cancer called triple A breast cancer that has spread to other parts of the body and who can’t have surgery to remove it.
A guide to intermediate care services that provide support for a short time to help you recover and increase your independence
Guide for young people and their families about being assessed for autism
Everything NICE has said on diagnosing and managing the epilepsies in adults and children in primary and secondary care in an interactive flowchart
Our tool to help you plan for and implement NICE guidance. View upcoming guidance and understand the impact of guidance on your resources. Previously known as the forward planner.
Public Health Advisory Committees (PHACs) are the standing committees responsible for the development of NICE public health guidance. Each PHAC...
The guideline covers diagnosing, treating and managing epilepsy and seizures in children, young people and adults in primary and secondary care. It offers best practice advice on managing epilepsy to improve health outcomes so that people with epilepsy can fully participate in daily life.
Evidence-based recommendations on idelalisib (Zydelig) for follicular lymphoma that has not responded to 2 prior lines of treatment in adults
NICE indicators. NM03 epilepsy guidance.
Everything NICE has said on diagnosing and managing non-Hodgkin's lymphoma in adults and young people 16 years and older in an interactive flowchart
Contact the Office for Market Access (OMA)
Apply for a NICE fellowship
Apply for a NICE scholarship
Access and insight for international organisations into the way we work. Learn about our products and the processes and methods we use to develop them.
There were more than 626,000 births in the NHS in 2017/18, with around 100,000 neonatal admissions to hospital each year. This report focuses on
Everything NICE has said on managing ulcerative colitis in adults, children and young people in an interactive flowchart
Everything NICE has said on severe mental illness and substance misuse (dual diagnosis) for people over 14 in community services in an interactive flowchart
Everything NICE has said on diagnosing and managing colorectal cancer in an interactive flowchart
The NICE scientific advice team
Our impact reports look at how the health and care system uses NICE's recommendations to improve people's health and care.
NICE Medicines and technologies programme: adoption team
A quick, easy way to access key information from NICE on social care topics.
How the health and care system uses our recommendations to improve outcomes in priority areas.
Evidence-based antimicrobial prescribing guidance for primary and secondary care with a focus on bacterial infection and antibiotic use.
This guideline sets out an antimicrobial prescribing strategy for adults, young people, children and babies aged 72 hours and over with cellulitis and erysipelas. It aims to optimise antibiotic use and reduce antibiotic resistance.
Everything NICE has said on antimicrobial prescribing for cellulitis and erysipelas in an interactive flowchart
NICE has said that a new drug for preventing migraine is not a cost effective use of NHS resources, in final draft guidance published today (26 September 2019).
Operations are set to start taking place in the NHS
Regularly monitoring women who are pregnant with twins or triplets, to spot any possible complications, can lead to better outcomes for mothers and their babies, as highlighted in NICE’s impact report.
Everything NICE has said on antimicrobial prescribing for common infections in an interactive flowchart
Everything NICE has said on managing skin conditions and skin damage in an interactive flowchart
Everything NICE has said on preventing and controlling healthcare-associated infections in an interactive flowchart
Everything NICE has said on preventing and managing pressure ulcers in all age groups in primary care and community settings in an interactive flowchart
NICE guidelines are evidence-based recommendations for health and care in England.
1 Abortion before 14 weeks: choosing between medical or surgical abortion Decision aid c NICE 2019. All rights reserved. Subject to Notice of rights.
1 Abortion from 14 weeks up to 24 weeks: choosing between medical or surgical abortion Decision aid c NICE 2019. All rights reserved. Subject to...
Evidence-based recommendations on bioprosthetic plug insertion for anal fistula in adults
Evidence-based recommendations on high-intensity focused ultrasound for glaucoma in adults